282 results on '"Hervig, T."'
Search Results
2. PB1537 Changes in Whole Blood Platelet Aggregation and Clotting Parameters during Pregnancy and Postpartum in Women with and without Heterozygous Factor V Leiden Mutation
3. P‐PH‐4 | Putting Blood Donors at the Heart of Infectious Disease Surveillance
4. Putting blood donors at the heart infectious disease surveillance
5. Cold stored platelets in treatment of bleeding
6. Experiences with semi‐routine production of riboflavin and UV‐B pathogen‐inactivated platelet concentrates in three blood centres
7. A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment
8. The effect of blood donation frequency on iron status
9. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia
10. Evaluation of noninvasive methods for the estimation of haemoglobin content in red blood cell concentrates
11. Harvesting of mobilized peripheral blood stem cells alters the plasma cytokine profile in patients with multiple myeloma: P1098
12. S. M. Skulstad, T. Hervig & Ø. Flesland
13. A pilot study of the possibility and the feasibility of haemoglobin dosing with red blood cells transfusion
14. Pathogen inactivation of platelet concentrates
15. Inventory Management
16. Effect of iron supplementation on iron status during the first week after blood donation
17. Iron status in Norwegian blood donors: comparison of iron status in new blood donors registered in 1993–1997 and in 2005–2006
18. A PROSPECTIVE OBSERVATIONAL COHORT SAFETY STUDY OF 5,106 PLATELET TRANSFUSIONS PREPARED WITH PHOTOCHEMICAL TREATMENT (INTERCEPT™): P-379
19. Measurements of in vitro platelet quality parameters in photochemical treated and gamma-irradiated single-donor platelet concentrates during storage: 40
20. High prevalence of IgE antibodies among blood donors in Sweden and Norway
21. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells
22. The platelet count accuracy of platelet concentrates obtained by using automated analysis is influenced by instrument bias and activated platelet components
23. Endogenous glutathione and platelet function in platelet concentrates stored in plasma or platelet additive solution
24. The swirling phenomenon in stored platelets is influenced by their endogenous serotonin
25. A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial
26. Massive transfusion: changing practice in a single Norwegian centre 2002-2015
27. RBC alloantibody prevalence and specificity in a Western Norwegian tertiary hospital
28. Challenges and opportunities to prevent transfusion errors: a Qualitative Evaluation for Safer Transfusion (QUEST)
29. Challenges and opportunities to prevent transfusion errors: a Qualitative Evaluation for Safer Transfusion (QUEST)
30. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients
31. A prospective observational study on effects of fever on red cell transfusion outcome
32. Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres
33. RBC alloantibody prevalence and specificity in a Western Norwegian tertiary hospital.
34. Intraoperative transfusion practices in Europe
35. Implementing a patient blood management program in Norway: Where to start?
36. A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVAphotochemical treatment
37. Increased resolution within Y-chromosome haplogroup R1b M268 shed light on the neolithic transition in Europe
38. Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres.
39. Monitoring and treatment of anti-D in pregnancy
40. Where will pathogen inactivation have the greatest impact?
41. Plasma/platelet pathogen inactivation
42. Validation Studies in European Blood Centers To Evaluate Processing Whole-Blood-Derived or Apheresis Plasma Using the INTERCEPT Blood System Intended for Commercialization.
43. The INTERCEPT Blood System for Plasma: Process Validation Studies of Coagulation Factor Activity and Yield in Two European Blood Centers.
44. Practical Experience of Implementing the INTERCEPT™ Blood System for Buffy Coat Platelets in a Blood Center
45. Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals. Oral doses of vitamin B6 reduce concentrations of serum folate
46. Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals. Oral doses of vitamin B6reduce concentrations of serum folate
47. Effects of acute myelogenous leukemia blasts on platelet release of soluble P-selectin and platelet-derived growth factor
48. Endogenous serotonin in human blood platelets: factors that may influence reference values
49. Human blood platelet serotonin studiedin vitro: endogenous serotonin may stimulate thrombin-induced serotonin release in stored platelets
50. Fatty Acids in Human Platelets and Plasma. Dietary Seal Oil Decreases Sensitivity Toward Microbubbles
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.